Background In 2009, 3 genome-wide association studies implicated IL28B single-nucleotide
polymorphisms (SNPs) as the strongest genetic pretreatment predictor of sustained …

Background Despite significant advances in the treatment of chronic hepatitis C in the past
decades, factors which can affect response rates to combination therapy; peginterferon and …

Background Treatment guidelines contraindicate ribavirin for treatment of hepatitis C virus
(HCV) infection in thalassemia major patients. Nevertheless, the current evidence suggests …

Objectives To provide a clear picture of available data, we performed a systematic review of
the epidemiological characteristics of HCV infection among patients with inherited …

Ribavirin (RBV)-induced anemia is a serious side effect of pegylated interferon (PEG-IFN)
plus RBV therapy which is the standard care most effective for hepatitis C virus (HCV) …

Background Hepatitis C is a major reason of morbidity and mortality among hemophilia
patients. Although combination therapy with peginterferon (peg-INF) and ribavirin is …

Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are the major causes of liver
disease worldwide and the health policy makers with their strategies try to control these …

Aim: The aim of our study was to investigate the correlation between the presence of plus-
/minus-strand HCV RNA in peripheral blood mononuclear cells (PBMCs) and serum …

Hepatitis C virus (HCV) infection is a common global health problem. Special patient
populations such as those with thalassemia, hemophilia and on hemodialysis are at higher …

سابقه و هدف: عفونت مزمن هپاتيت C در مبتلايان هموفيلي معضلي اساسي محسوب مي شود. شواهد
چنداني از کارايي و عواقب طولاني مدت درمان اين بيماران در دست نيست. هدف از اين مطالعه، ارزيابي …‎